Power Law company profile

Genmab

Biotech & Life Sciences · Copenhagen, Denmark · Founded 1999 · IPO 2000 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$20B

Market cap · Apr/2026

Revenue

$3.72B

Latest reported FY

Investors

6 investors on Genmab's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 6 investors entered at this stage

BankInvest

Apax Partners

Lombard Odier

Dansk Erhvervsinvestering

LODH Immunology Fund

Medicxi

Global footprint

Where Genmab has talent and traffic

AI talent share

1.8% of workforce is AI talent
(52 of 2,836 staff)

Core AI130.46%

Other AI391.38%

Non-AI workforce2,78498.17%

Web traffic by country

110K monthly visits
across markets

🇺🇸 United States32.3%

🇩🇰 Denmark22%

🇳🇱 Netherlands17.9%

🇯🇵 Japan6.5%

🇨🇦 Canada3.1%

Top 5 markets shown

Patent intelligence

$328M patent portfolio · 202 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$328M

1.7% of market cap · 2.5× the top peer Alder Biopharmaceuticals ($129M)

202 active patent families

Where Genmab innovates Antiendomysial antibodiesMolecular biologyPharmaceutical drugCancer researchImmunology

Above peer median on Legal, Strategic, Market

Quality vs same-sector peers

Genmab on the five Patsnap quality dimensions

Genmab in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Genmab concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Genmab and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Genmab on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo